Skip to search formSkip to main contentSkip to account menu

Dicumarol

Known as: Bis(4-hydroxycoumarin-3-yl)methane, 2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy)-, bis-hydroxycoumarin 
An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
The course of long-term anticoagulant therapy in 114 out-patients has been evaluated over a three-month period. The evaluation… 
2009
2009
. A comparison has been made between the following methods used to control dicumarol therapy: P&P (human thromboplastin… 
1981
1981
The dissolution characteristics of dicumarol were markedly enhanced by preparing dispersions of drug in polyethylene glycol 4000… 
1973
1973
THE effect of the dicoumarol drugs on clotting factor biosynthesis is similar to that of vitamin K deficiency, in that the… 
Highly Cited
1968
Highly Cited
1968
A widely used method for the determination of bishydroxycoumarin (BHC) in plasma, which involves extraction of BHC from acidified… 
1966
1966
The morphology of the salivary gland chromosomes of six North American species of the genus Prosimulium was studied. Five of… 
1962
1962
At the present time, hypoprothrombinemia induced by anticoagulant drugs is the most commonly encountered coagulation defect in… 
1944
1944
Excerpt Interest in anti-coagulants as therapeutic agents has encouraged the trial of various substances in conditions…